Elanco Animal Health Gross Margin 2016-2023 | ELAN

Current and historical gross margin for Elanco Animal Health (ELAN) over the last 10 years. The current gross profit margin for Elanco Animal Health as of December 31, 2023 is %.
Elanco Animal Health Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2023-12-31 $4.42B $2.49B 56.28%
2023-09-30 $4.37B $2.50B 57.33%
2023-06-30 $4.32B $2.48B 57.26%
2023-03-31 $4.44B $2.54B 57.27%
2022-12-31 $4.41B $2.50B 56.63%
2022-09-30 $4.54B $2.56B 56.49%
2022-06-30 $4.64B $2.64B 56.83%
2022-03-31 $4.75B $2.68B 56.36%
2021-12-31 $4.76B $2.63B 55.25%
2021-09-30 $4.79B $2.57B 53.69%
2021-06-30 $4.55B $2.39B 52.55%
2021-03-31 $3.86B $1.95B 50.64%
2020-12-31 $3.27B $1.60B 49.04%
2020-09-30 $2.92B $1.44B 49.30%
2020-06-30 $2.80B $1.40B 50.07%
2020-03-31 $3.00B $1.54B 51.33%
2019-12-31 $3.07B $1.60B 52.13%
2019-09-30 $3.08B $1.61B 52.25%
2019-06-30 $3.07B $1.59B 51.77%
2019-03-31 $3.06B $1.50B 49.13%
2018-12-31 $3.07B $1.49B 48.70%
2018-06-30 $2.20B $1.04B 47.03%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $6.685B $4.417B
Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.269B 10.45
Quest Diagnostics (DGX) United States $15.262B 15.77
DaVita (DVA) United States $11.791B 14.65
Chemed (CHE) United States $8.503B 26.36
Encompass Health (EHC) United States $8.378B 21.45
Option Care Health (OPCH) United States $5.181B 19.61
RadNet (RDNT) United States $3.783B 102.40
Amedisys (AMED) United States $3.009B 21.32
LifeStance Health (LFST) United States $2.546B 0.00
Astrana Health (ASTH) United States $2.099B 26.20
Addus HomeCare (ADUS) United States $1.608B 24.43
U.S Physical Therapy (USPH) United States $1.585B 41.09
Pennant (PNTG) United States $0.642B 37.54
Aveanna Healthcare Holdings (AVAH) United States $0.448B 0.00
Atai Life Sciences (ATAI) Germany $0.343B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.026B 0.00
ATI Physical Therapy (ATIP) United States $0.019B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.011B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00